Paysign, Inc.
Close on Oct 19, 2026
- Market cap
- $950.70M
- P/E (TTM)
- 59.0
- Dividend yield
- –
Earnings
Next report expected Nov 11, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 5, 2026 | After market close | $28.25M | $0.11 | $0.16 |
| Q1 FY2026 Ended Mar 31, 2026 | May 12, 2026 | After market close | $28.04M | $0.09 | $0.17 |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 24, 2026 | After market close | $22.76M | $0.02 | $0.09 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 12, 2025 | After market close | $21.60M | $0.04 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 5, 2025 | After market close | $19.08M | $0.02 | $0.08 |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | After market close | $18.60M | $0.05 | $0.09 |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 25, 2025 | After market close | $15.61M | $0.02 | $0.05 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 5, 2024 | After market close | $15.26M | $0.03 | $0.05 |
| Q2 FY2024 Ended Jun 30, 2024 | Jul 31, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 26, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 5, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | Full Year 2026 | $35.00M to $38.00M | Raised |
| Adjusted EBITDAnon-GAAP | Third Quarter 2026 | $9.50M to $10.00M | New |
| Adj. EBITDA per diluted sharenon-GAAP | Full Year 2026 | $0.57 to $0.61 | Raised |
| Adj. EBITDA per diluted sharenon-GAAP | Third Quarter 2026 | $0.15 to $0.16 | New |
| Diluted EPSGAAP | Full Year 2026 | $0.35 to $0.37 | Raised |
| Diluted EPSGAAP | Third Quarter 2026 | $0.09 to $0.10 | New |
| Gross margin | Full Year 2026 | 62% to 63% | Raised |
| Gross margin | Third Quarter 2026 | 61% to 63% | New |
| Revenue growth (YoY) | Full Year 2026 | 39% to 43% growth | Raised |
| Net incomeGAAP | Full Year 2026 | $21.50M to $23.00M | Raised |
| active patient affordability programs | third quarter of 2026 | 165 to 170 | New |
| plasma centers | third quarter of 2026 | 561 to 563 | Raised |
| Revenue growth (YoY) | Third Quarter 2026 | 32% to 38.9% growth | New |
| Net incomeGAAP | Third Quarter 2026 | $5.70M to $6.00M | New |
| Revenue | Full Year 2026 | $114.00M to $117.00M | Raised |
| Revenue | Third Quarter 2026 | $28.50M to $30.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Paysign filed with the SEC
Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million,
Results of operations · EX-99.1 to Form 8-K
Paysign’s Patient Affordability Drives 51% Revenue Growth and
Results of operations · EX-99.1 to Form 8-K
Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial
Results of operations · EX-99.1 to Form 8-K
Paysign, Inc. Reports Third Quarter 2025 Financial Results
Results of operations · EX-99 to Form 8-K
NOTICE OF PENDENCY AND PROPOSED SETTLEMENT
Regulation FD disclosure · EX-99.1 to Form 8-K
STIPULATION AND AGREEMENT OF SETTLEMENT
Regulation FD disclosure · EX-99.2 to Form 8-K
HENDERSON, Nev. – September 15,
Regulation FD disclosure · EX-99.3 to Form 8-K
Paysign, Inc. Reports Second Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Paysign, Inc. Reports First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ENTITLED PAYSIGN, INC. REPORTS FISCAL YEAR 2024 FINANCIAL RESULTS
Results of operations · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE ENTITLED PAYSIGN, INC. ANNOUNCES ACQUISITION OF GAMMA INNOVATION'S ASSETS, APPOINTS MICHAEL NGO AS CHIEF INNOVATION OFFICER, PAYSIGN STRENGTHENS LEADERSHIP IN TECHNOLOGY FOR PLASMA AND PHARMACEUTICAL INDUSTRIES
Results of operations · Unregistered share sale · Regulation FD disclosure · EX-99.2 to Form 8-K
Paysign, Inc. Reports Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Paysign, Inc. Reports Second Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Paysign, Inc. Reports First Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Paysign, Inc. Reports Fourth Quarter and Full-Year 2023 Financial
Results of operations · EX-99.1 to Form 8-K
Paysign, Inc. Reports Third Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Paysign, Inc. Reports Second Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Paysign, Inc. Reports First Quarter 2023
Results of operations · EX-99.1 to Form 8-K
Paysign, Inc. Announces New $5,000,000 Stock
Regulation FD disclosure · EX-99.1 to Form 8-K
Paysign, Inc. Reports Fourth Quarter and
Results of operations · EX-99.1 to Form 8-K
Inc. Reports Third Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Paysign, Inc. Reports Second Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Paysign Announces Changes to the Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Inc. Reports First Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Inc. Reports Fourth Quarter and Full Year 2021
Results of operations · EX-99.1 to Form 8-K
Reports Third-Quarter 2021 Financial Results
Results of operations · EX-99.1 to Form 8-K